<unk>  (PTLS), also known as dup(17)p11.2p11.2 syndrome, trisomy 17p11.2 or duplication 17p11.2 syndrome, is a contiguous gene syndrome involving the microduplication of band 11.2 on the short arm of human chromosome 17 (17p11.2). The duplication was first described as a case study in 1996. In 2000, the first study of the disease was released, and in 2007, enough patients had been gathered to complete a comprehensive study and give it a detailed clinical description. PTLS is named for two researchers involved in the latter phases, Drs. Lorraine<unk>  and James R.<unk>  of Baylor College of Medicine. PTLS was the first predicted reciprocal of a homologous recombination (microdeletion or microduplication) where both reciprocal recombinations result in a contiguous gene syndrome. Its reciprocal disease is Smith–Magenis syndrome (SMS), in which the chromosome portion duplicated in PTLS is deleted altogether.<unk>  is considered a rare disease, predicted to appear in at least 1 in 20,000 humans. Symptoms of the syndrome include intellectual disability, autism, and other disorders unrelated to the listed symptoms.
Potocki–Lupski syndrome
Young–Madders syndrome
Lujan–Fryns syndrome
Fox–Fordyce disease
Townes–Brocks syndrome
Frasier syndrome
Young–Simpson syndrome
Fowler's syndrome